Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123303434 | 12330343 | 4 | F | 201602 | 20160803 | 20160504 | 20160810 | EXP | DK-DKMA-WBS-0003138 | DK-UCBSA-2016015868 | UCB | 41.52 | YR | F | Y | 75.00000 | KG | 20160810 | MD | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123303434 | 12330343 | 1 | PS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | 200 MG, EV 2 WEEKS(QOW) STYRKE: 200 MG, EVERY 14 DAY | Y | U | 177733 | 125160 | 200 | MG | SOLUTION FOR INJECTION | QOW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123303434 | 12330343 | 1 | Arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123303434 | 12330343 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123303434 | 12330343 | Chest discomfort | |
| 123303434 | 12330343 | Chest pain | |
| 123303434 | 12330343 | Dizziness | |
| 123303434 | 12330343 | Dyspnoea | |
| 123303434 | 12330343 | Malaise | |
| 123303434 | 12330343 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123303434 | 12330343 | 1 | 201512 | 201603 | 0 |